entinostat and rgfp966
entinostat has been researched along with rgfp966 in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bourguet, E; Jeanblanc, J; Moroy, G; Naassila, M; Ozdarska, K | 1 |
| Cao, F; Dekker, FJ; Ettema, PE; Quax, WJ; van Merkerk, R; Zwinderman, MRH | 1 |
| Chen, L; Gu, Z; He, B; Li, Y; Lin, S | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Hoffmann, MJ; Hommel, K; Meneceur, S; Niegisch, G; Schulz, WA | 1 |
Reviews
2 review(s) available for entinostat and rgfp966
| Article | Year |
|---|---|
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD).
Topics: Alcoholism; Animals; Epigenomics; Histone Deacetylase Inhibitors; Humans; Therapeutics | 2018 |
Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Neoplasms; Zinc | 2022 |
Other Studies
3 other study(ies) available for entinostat and rgfp966
| Article | Year |
|---|---|
Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
Topics: Anilides; Animals; Benzamides; Catalytic Domain; Gene Expression; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inflammation; Interleukin-10; Interleukin-6; Macrophages; Mice; Molecular Docking Simulation; NF-kappa B p50 Subunit; Nitric Oxide Synthase Type II; Protein Binding; RAW 264.7 Cells; Stereoisomerism; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Downregulation of Cell Cycle and Checkpoint Genes by Class I HDAC Inhibitors Limits Synergism with G2/M Checkpoint Inhibitor MK-1775 in Bladder Cancer Cells.
Topics: Acrylamides; Benzamides; Cell Cycle Checkpoints; Cell Line, Tumor; Depsipeptides; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Genes, cdc; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Phenylenediamines; Pyrazoles; Pyridines; Pyrimidinones; Urinary Bladder Neoplasms | 2021 |